Innovation Index

Maternova conducts ongoing research into new tools that save lives. In the Innovation Index we post tools on the market and those still in research and development. We cover light, power, transport, structures, systems, IT, devices, vaccines, you name it. Innovation that saves maternal and newborn lives from every angle.

  • "xylitol chewing gum", "preterm birth", "Baylor", Malawi, preterm birth
    February 02, 2012

    Xylitol chewing gum is a potential low-cost method of preventing preterm birth. The intervention is currently being tested in Malawi under a Saving Lives at Birth two-year grant. Gum disease is a documented cause of preterm birth, but the idea of testing xylitol chewing gum to prevent preterm birth in the developing world is the brainchild of Dr. Kjersti Aagaard, assistant professor of obstetrics and gynecology at Baylor College of Medicine. (The Face of Malawi)[http://www.faceofmalawi.com/2011/09/could-chewing-gum-help-lower-rates-of-premature-births-in-malawi/] reports that the research in Malawi will involve testing a series of different gums and mints to prevent gum disease.

  • January 23, 2012

    The Hospital for Sick Children in Toronto, Canada, through its affiliate SickKids are developing a daily microencapsulated micronutrient powder that contains iron, folic acid, and calcium called "Prenatal Sprinkles." The prenatal supplements are to be taken by pregnant women in rural settings and can potentially reduce maternal hypertensive disease related mortality by 20% and preterm birth by 24%. The powder will contain differential time-released nutrients, help with iron and calcium absorption, prevent calcium-iron interactions and have a smooth texture and appealing flavor.

  • January 23, 2012

    Global Solutions for Infectious Diseases from CA is developing a low-cost rapid diagnostic test that will accurately diagnose and report anemia, HIV, syphilis, and malaria. The hand-held instrument will read and record test results as well as report the results in real time through automated wireless reports to health authorities. This data will allow for disease tracking in order to make decisions based on resource availability. As of now, the organization is working on multi-testing ability of the instrument as well as the reading of barcodes for management of pharmaceutical products. This technology came to our attention through Saving Lives at Birth Challenge, 2011.

  • solar-powered infant warmer, hypothermia
    January 23, 2012

    The Program for Appropriate Technology In Health is developing a solar-powered infant warmer to provide initial warmth before skin-to-skin care is provided to prevent infant death by hypothermia. The warmers lightweight photovoltaic modules developed by HighFlex Solar, Inc and phase-change material will be used to store and maintain heat. It will also include a temperature monitoring device. The warmer will be less than $200 and is currently in development. A two year grant will be used to design and test the warmer until introducing a final design. This technology came to our attention through the Saving Lives at Birth Challenge, 2011.

  • "hand sanitizer", "safe birth kits", Byotrol, "appropriate technology"
    January 23, 2012

    The Program for Appropriate Technology in Health has developed a sanitizer and disinfectant called Byotrol to be used during birthing. Byotrol is an antimicrobial disinfectant in a water-based foaming formulation. Byotrol is to be used in health settings in developing countries where water and soap and alcohol-based sanitizer are not easily available or adapted by health care workers. PATH is the recipient of a two-year grant that will be used to evaluate the use of Byotrol against the protocol disinfectants and will determine provider acceptability, efficacy, and feasibility. This technology came to our attention through the Saving Lives at Birth Challenge, 2011.

  • blood safety microchip, blood screening, "appropriate technology", blood banks
    January 23, 2012

    The Regents of the University of California are developing a blood safety microchip that can assess the safety of donated blood used for transfusions. The chip is a miniature, quick, point of care device that tests for blood-borne infections using enzyme-linked immunoassay and nucleic acid test kits. The ELISA and NAT will alert to the presence of HIV, hepatitis C virus, hepatitis B virus, and CD4 t-cell counts. The microchip can greatly increase the safety of blood transfusions which are often inadequately screened for viral infections but are needed during obstetrical hemorrhages. This technology came to our attention through the Saving Lives at Birth Challenge, 2011.

  • November 29, 2011

    The University of Maryland Baltimore and General Electric's Maternal Infant Care division are developing an inexpensive incubator and ventilator to be used in low resource healthcare settings. Currently, they are working on creating an inexpensive incubator-warmer-cooler-transporter and portable ventilator. Research on the technologies will be done in Southern India.

    There is no further information available at this time.